University of Maryland School of Medicine and MRIGlobal in Collaboration Agreement

MRIGlobal's picture
Printer-friendly versionPrinter-friendly versionPDF versionPDF version

Agreement Focuses on Development of Clinical Specimen Repositories, Laboratory Services, and Research

(Kansas City, MO) March 14, 2014 – MRIGlobal and the University of Maryland School of Medicine today announced an intention to collaborate in the development of clinical specimen repositories, laboratory services for clinical trials, and research opportunities. The work will be performed under the collaboration agreement by MRIGlobal Dx, a division of MRIGlobal. 

The non-exclusive memo of understanding has an initial two-year term, with annual renewals ongoing. Other terms of the agreement were not released.

With the agreement, the University of Maryland School of Medicine and MRIGlobal Dx plan to explore opportunities for procurement of clinical samples and patient specimen collection and banking.

Researchers in molecular and translational medicine use specimen repositories to develop new ways to diagnose, prevent, or treat diseases. Specimens may include fluids, tissues, tumors, cells and genetic material.  

“This is a powerful agreement between two organizations committed to excellence and advancing knowledge,” said Thomas M. Sack, Ph.D., President and Chief Executive Officer of MRIGlobal. “We are delighted to collaborate with the University of Maryland School of Medicine in bringing new diagnostic products and therapeutics to market.”

University of Maryland School of Medicine Dean E. Albert Reece, who is Vice President for Medical Affairs at the University of Maryland and the John Z. and Akiko Bowers Distinguished Professor at the School of Medicine, commented:  “As we continue to develop our resources as a top biomedical research institution, this agreement provides a critical service for our laboratories and clinical trials.

“We are excited to partner with a leading firm like MRIGlobal in this endeavor,” he said.

About the University of Maryland School of Medicine
Established in 1807, the University of Maryland School of Medicine was the first public medical school in the United States, and the first to institute a residency-training program. The School of Medicine was the founding school of the University of Maryland and today is an integral part of the 11-campus University System of Maryland. On the University of Maryland's Baltimore campus, the School of Medicine serves as the anchor for a large academic health center which aims to provide the best medical education, conduct the most innovative biomedical research and provide the best patient care and community service to Maryland and beyond. www.medschool.umaryland.edu.

About MRIGlobal Dx
MRIGlobal Dx provides fee-for service assay development for menu expansion in in vitro and molecular diagnostics, validation and clinical testing, and platform engineering and integration. MRIGlobal Dx operates a Clinical Laboratory Improvement Amendments (CLIA)-laboratory accredited by the College of American Pathologists. MRIGlobal Dx is ISO 9001 certified and employs current Good Manufacturing Practices and Good Laboratory Practices, and maintains Biosafety Level 3 laboratories.

News Source : University of Maryland School of Medicine and MRIGlobal in Collaboration Agreement

Copy this html code to your website/blog to embed this press release.